Deerfield Management Company, L.P. (Series C) Delcath Systems, Inc. Call Options Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.35 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DCTH
# of Institutions
121Shares Held
13.2MCall Options Held
108KPut Options Held
40.5K-
Vanguard Group Inc Valley Forge, PA1.61MShares$17.5 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il803KShares$8.74 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA703KShares$7.65 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA570KShares$6.2 Million1.64% of portfolio
-
Marshall Wace, LLP London, X0483KShares$5.26 Million0.01% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $93.5M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...